Skip to main content
. 2001 Jun;133(4):459–466. doi: 10.1038/sj.bjp.0704082

Figure 2.

Figure 2

Effect of the 5-HT2A receptor antagonist MDL100,907 (0.5 mg kg−1; A) and the 5-HT2B receptor antagonist SB215,505 (3 mg kg−1; B) against the hyperactivity and wet-dog shakes produced by the combination of Ro60-0175 (10 mg kg−1) and SB242,084 (0.5 mg kg−1) (RoSB group). n=6–8 rats per group. *P<0.05 vs vehicle/vehicle group. #P<0.05 vs RoSB/veh group (Newman-Keuls test).